CONMED Net Income 2010-2023 | CNMD

CONMED net income from 2010 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
CONMED Annual Net Income
(Millions of US $)
2023 $64
2022 $-81
2021 $63
2020 $10
2019 $29
2018 $41
2017 $55
2016 $15
2015 $30
2014 $32
2013 $36
2012 $40
2011 $1
2010 $30
2009 $12
CONMED Quarterly Net Income
(Millions of US $)
2023-12-31 $33
2023-09-30 $16
2023-06-30 $14
2023-03-31 $2
2022-12-31 $27
2022-09-30 $46
2022-06-30 $-168
2022-03-31 $15
2021-12-31 $24
2021-09-30 $15
2021-06-30 $13
2021-03-31 $10
2020-12-31 $24
2020-09-30 $7
2020-06-30 $-27
2020-03-31 $6
2019-12-31 $15
2019-09-30 $7
2019-06-30 $6
2019-03-31 $1
2018-12-31 $16
2018-09-30 $6
2018-06-30 $9
2018-03-31 $11
2017-12-31 $47
2017-09-30 $7
2017-06-30 $6
2017-03-31 $-5
2016-12-31 $7
2016-09-30 $7
2016-06-30 $3
2016-03-31 $-2
2015-12-31 $8
2015-09-30 $9
2015-06-30 $7
2015-03-31 $6
2014-12-31 $11
2014-09-30 $2
2014-06-30 $10
2014-03-31 $9
2013-12-31 $10
2013-09-30 $6
2013-06-30 $10
2013-03-31 $10
2012-12-31 $11
2012-09-30 $9
2012-06-30 $10
2012-03-31 $10
2011-12-31 $-25
2011-09-30 $8
2011-06-30 $9
2011-03-31 $9
2010-12-31 $7
2010-09-30 $9
2010-06-30 $7
2010-03-31 $7
2009-12-31 $5
2009-09-30 $1
2009-06-30 $1
2009-03-31 $4
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.240B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $69.110B 18.50
Becton Dickinson (BDX) United States $67.086B 19.48
West Pharmaceutical Services (WST) United States $27.625B 46.70
Cardinal Health (CAH) United States $25.909B 15.57
Align Technology (ALGN) United States $22.586B 45.54
Cooper (COO) United States $17.860B 27.03
Labcorp (LH) United States $16.823B 14.37
Henry Schein (HSIC) United States $9.019B 15.60
DENTSPLY SIRONA (XRAY) United States $6.296B 16.59
Merit Medical Systems (MMSI) United States $4.152B 23.76
Patterson (PDCO) United States $2.305B 11.04
STAAR Surgical (STAA) United States $2.264B 71.29
Atrion (ATRI) United States $0.702B 36.15
Lifevantage (LFVN) United States $0.085B 13.75
Pro-Dex (PDEX) United States $0.064B 24.35
Biolase (BIOL) United States $0.005B 0.00